Virpax Pharmaceuticals, Inc. (VRPX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -2.87M | -4.47M | -1.64M | -7.73M | -3.01M | -2.65M | -2.18M | -2.01M | -1.57M | -5.5M | -4.74M | -6.04M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 4.68% | -68.59% | 24.71% | -284.86% | -92.14% | 51.79% | 53.91% | 66.78% | 68.16% | -15.94% | -163.48% | -96.25% |
| Net Income | -3.39M | -2.01M | -3.45M | -3.22M | -4.56M | -5.99M | -3.11M | -1.52M | -2.99M | -7.64M | -5.88M | -5.14M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 7.2K | -17.73K | 72.51K | 72.72K | -9.63K | 195.56K | 218.26K | 140.58K | 138.28K | 150.72K | 244.7K | 211.34K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 0 | 0 | 0 | 72.72K | -9.63K | 195.56K | 218.26K | 140.58K | 138.28K | 150.72K | 244.7K | 211.34K |
| Working Capital Changes | 512.2K | -2.45M | 1.73M | -4.58M | 1.56M | 3.15M | 711.59K | -628.42K | 1.28M | 1.99M | 904.01K | -1.12M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | -223.81K | 1.19M | -304.18K | 599.23M | 0 | 352.53K | 199.65K | -3.11M | 1.72M | 296.48K | 99.2K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 4.37M | 2.62M | 1.65M | 453.95K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 4.07M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 299.21K | 2.62M | 1.65M | 453.95K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 1.5M | -1.85M | 4.6K | -7.28M | -3.01M | -2.65M | -2.18M | -2.01M | -1.57M | -5.5M | -4.74M | -6.04M |
| Free Cash Flow | -2.87M | -4.47M | -1.64M | -7.73M | -3.01M | -2.65M | -2.18M | -2.01M | -1.57M | -5.5M | -4.74M | -6.04M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 4.68% | -68.59% | 24.71% | -284.86% | -92.14% | 51.79% | 53.91% | 66.78% | 68.16% | -15.94% | -163.48% | -96.25% |
| FCF per Share | -0.67 | -0.96 | -0.83 | -6.60 | -2.57 | -2.26 | -1.86 | -1.71 | -1.34 | -0.47 | -0.40 | -0.52 |
| FCF Conversion (FCF/Net Income) | 0.85x | 2.23x | 0.48x | 2.40x | 0.66x | 0.44x | 0.70x | 1.44x | 0.55x | 0.73x | 0.81x | 1.17x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |